Press Releases
Search
-
26 Oct 2007
Business Review for the nine months ended September 30, 2007 Nine-month sales up 6.9% like-for-like
Marcy l'Etoile, France - October 26, 2007. bioMérieux (Euronext: BIM), a global leader in the field of in vitro diagnostics, today released its business review for the nine months ended September 30, ...
-
18 Oct 2007
FDA Clears bioMérieux’s VIDAS® B·R·A·H·M·S PCT® Assay A First Indication for Sepsis Risk Assessment in the ICU
Marcy l’Etoile (France) - Oct. 18, 2007. bioMérieux (Euronext: BIM), a world leader in the field of in vitro diagnostics, has received 510(k) clearance from the U.S. Food and Drug Administration to ma...
-
08 Oct 2007
bioMérieux and Compliance Software Solutions Corp. Partner to Enhance Data Management for the Pharmaceutical Industry
Marcy l’Etoile (France) - Oct. 8, 2007. bioMérieux, a leading industrial microbiology and in vitro diagnostics company, has signed an exclusive global sales representative agreement with Compliance So...
-
01 Oct 2007
bioMérieux Launches VIDAS® NT-proBNP, an Aid for Diagnosis and Prognosis of Heart Failure
Marcy l’Etoile (France) - October 1, 2007. bioMérieux, a global leader in the field of in vitro diagnostics, announces the launch of VIDAS® NT-proBNP, a CE-approved test that helps the diagnosis and p...
-
27 Sep 2007
Early Diagnosis of Sepsis: bioMérieux presents new Sepsis Handbook at International Sepsis Forum
Marcy l’Etoile (France) - Sept. 26, 2007. bioMérieux, a global leader in the field of in vitro diagnostics, today announces the launch of the “Sepsis Handbook”. This comprehensive book, produced by bi...
-
17 Sep 2007
First–Half 2007 Financial Results Sales up 6.7% like-for-like
Marcy l'Etoile, France - Sept. 17, 2007. bioMérieux, a global leader in the field of in vitro diagnostics, today announced its results for the six months ended June 30, 2007. - First–Half 2007 Financi...